Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6255)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2022 (publication date) through Aug 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song JP, Liu XZ, Chen Q, Liu YF. High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma. World J Clin Cases 2022; 10(3): 790-801 [PMID: 35127895 DOI: 10.12998/wjcc.v10.i3.790] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i3/790.htm |
| Number | Citing Articles |
| 1 |
Mei Chen, Zhenyu Nie, Yuanhui Gao, Hui Cao, Linlin Zheng, Na Guo, Yanling Peng, Shufang Zhang. m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.900006
|
| 2 |
ATIEH POURBAGHERI-SIGAROODI, FATEMEH FALLAH, MAJID MOMENY, NIMA REZAEI, DAVOOD BASHASH. Unveiling the predictive power of bacterial response-related genes signature in hepatocellular carcinoma: with bioinformatics analyses and experimental approaches. BIOCELL 2024; 48(12): 1781 doi: 10.32604/biocell.2024.055848
|
| 3 |
Wei Luo, Feng Liu, Mengyu Li, Jialong Yu, Ziyun Liu, Xuan Cheng, Yue Huang, Yu Liu, Mei Tao, Yuqi Wang, Yiping Zou, Xiaobin Shang, Chao Yang, Xianhui Ruan, Yanchao Qin, Xiangqian Zheng. Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00288-z
|
| 4 |
Guoliang Chen, Song Li, Adong Xia, Yuelong Xing, Wenbo Liang. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma. The American Surgeon™ 2024; 90(6): 1481 doi: 10.1177/00031348241241730
|
| 5 |
R. Connor Chick, Samantha M. Ruff, Timothy M. Pawlik. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2024.47
|
| 6 |
Fang-Ju Huang, Ye-Ying Fang, Jia-Ying Wen, Jian-Jun Li, Qian Lin, Qin-Yan Su, Yi-Yang Chen, Lei Wang, Jian-Jia Zeng, Bang-Teng Chi, Rong-Quan He, Di-Yuan Qin, Li-Hua Yang, Gang Chen. From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2024.2444697
|
| 7 |
Yue Jiang, Yingquan Ye, Yi Huang, Yue Wu, Gaoxiang Wang, Zhongxuan Gui, Mengmeng Zhang, Mei Zhang. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15069 doi: 10.1007/s00432-023-05285-x
|
| 8 |
Zachary J. Brown, Satyajit Patwardhan, Joal Bean, Timothy M. Pawlik. Molecular diagnostics and biomarkers in cholangiocarcinoma. Surgical Oncology 2022; 44: 101851 doi: 10.1016/j.suronc.2022.101851
|
| 9 |
Michael H. Storandt, Peter C. Kurniali, Amit Mahipal, Zhaohui Jin. Targeted Therapies in Advanced Cholangiocarcinoma. Life 2023; 13(10): 2066 doi: 10.3390/life13102066
|
| 10 |
Ruyin Chen, Dandan Zheng, Qiong Li, Shuaishuai Xu, Chanqi Ye, Qi Jiang, Feifei Yan, Yunlu Jia, Xiaochen Zhang, Jian Ruan. Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers. Cancer Letters 2022; 546: 215853 doi: 10.1016/j.canlet.2022.215853
|
| 11 |
Jun-Jie Liu, Mi Zhou, Tong Yuan, Zhi-Yong Huang, Zun-Yi Zhang. Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges. World Journal of Gastroenterology 2025; 31(15): 104901 doi: 10.3748/wjg.v31.i15.104901
|
| 12 |
Pingping Yan, Yu Dong, Fenfen Zhang, Tiantian Zhen, Jiangtao Liang, Huijuan Shi, Anjia Han. Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts. Journal of Clinical Pathology 2024; : jcp-2023-209268 doi: 10.1136/jcp-2023-209268
|
| 13 |
Virag Gehl, Colm J. O’Rourke, Jesper B. Andersen. Immunogenomics of cholangiocarcinoma. Hepatology 2025; 82(2): 522 doi: 10.1097/HEP.0000000000000688
|